Dania Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.42M

  • Investors
  • 6

Dania Therapeutics General Information

Description

Developer of medicinal products designed for cancer and other related conditions. The company develops novel small-molecule therapies to treat acute myeloid leukemia (AML) and other life-threatening cancers, enabling doctors to treat cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O Nyborg & Rørdam Law Firm
  • Store Kongensgade 77
  • 1264 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • C/O Nyborg & Rørdam Law Firm
  • Store Kongensgade 77
  • 1264 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dania Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 18-Oct-2023 $2.42M Completed Pre-Clinical Trials
1. Joint Venture 31-Oct-2021 Completed Pre-Clinical Trials
To view Dania Therapeutics’s complete valuation and funding history, request access »

Dania Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Dania Therapeutics’s complete cap table history, request access »

Dania Therapeutics Patents

Dania Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025208385-A1 Wnk1 inhibitors Pending 10-Jan-2024
WO-2025149622-A1 Wnk1 inhibitors Inactive 10-Jan-2024
WO-2025149623-A1 Wnk1 inhibitors Inactive 10-Jan-2024 C07D471/04

Dania Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dania Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Denmark's Export and Investment Fund Venture Capital Minority
Eir Ventures Venture Capital Minority
Lundbeckfonden BioCapital Venture Capital Minority
University of Copenhagen University Minority
Hannibal Innovation Corporation Majority
You’re viewing 5 of 6 investors. Get the full list »

Dania Therapeutics FAQs

  • When was Dania Therapeutics founded?

    Dania Therapeutics was founded in 2021.

  • Where is Dania Therapeutics headquartered?

    Dania Therapeutics is headquartered in Copenhagen, Denmark.

  • What is the size of Dania Therapeutics?

    Dania Therapeutics has 1 total employees.

  • What industry is Dania Therapeutics in?

    Dania Therapeutics’s primary industry is Drug Discovery.

  • Is Dania Therapeutics a private or public company?

    Dania Therapeutics is a Private company.

  • What is the current valuation of Dania Therapeutics?

    The current valuation of Dania Therapeutics is .

  • What is Dania Therapeutics’s current revenue?

    The current revenue for Dania Therapeutics is .

  • How much funding has Dania Therapeutics raised over time?

    Dania Therapeutics has raised $2.42M.

  • Who are Dania Therapeutics’s investors?

    Denmark's Export and Investment Fund, Eir Ventures, Lundbeckfonden BioCapital, University of Copenhagen, and Hannibal Innovation are 5 of 6 investors who have invested in Dania Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process